2026. Treatment Retention and Hemoglobin Response During Darbepoetin Alfa and Recombinant Human Erythropoietin Beta Therapy in Children With CKD-Related Anemia: A Secondary Analysis of a Randomized Trial. The Planet. 10, 03 (Nov. 2026), 1103–1106. DOI:https://doi.org/10.5281/zenodo.23912066.